CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese mainland, Hong Kong SAR and Macau SAR, and Taiwan) from Cytokinetics in ...

A noteworthy case study. What's next for a premenopausal 40-year-old woman in Syria with recurrent hormone receptor-positive ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

[21] This was a smaller study that enrolled 74 patients 65 years and older with NYHA class II or III heart failure (defined by the Framingham criteria) and an ejection fraction ≥40%. Background ...

Cardiac diastolic dysfunction (CDD), ultimately leading to heart failure with preserved ejection fraction (HFpEF), is ...

Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF ... diastolic dysfunction had reduced ejection fractions (≤50%). Six of 13 people ...

Published by Elsevier Ltd. This substantial evidence challenges previously held beliefs about the similarity in mortality rates between individuals with heart failure and preserved ejection fraction ...

New research shows that cardiac MRI can predict sudden cardiac events in Fontan circulation, aiding clinical risk assessment.

Background Although the prognostic implications of severe mitral regurgitation (MR) are well recognised, they are less clear ...

Clinical Correlates and Prognostic Impact of Cognitive Dysfunction in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF. Circulation 2024;150:1913-27. Lu H, ...

and overall survival of patients with heart failure (HF) with reduced ejection fraction (rEF). However, despite its proven efficacy, precisely identifying suitable CRT candidates remains a challenge, ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten ...